XLXiangdi Li

Xiangdi Li

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Xiangdi Li has a total of 19 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Three-dimensional aperture-driven photoacoustic tomography (3D-ADPAT)

    by Xuanhao Wang, Yang Xiao, Yuqi Wang, Xiali Gao, Yongdu Ruan, Xiaohui Yang, Yiyin Su, Dikui Zhou, Xiangdi Li, Yuqian Meng, et al.

    As a powerful modality for biomedical research, photoacoustic computed tomography (PACT) offers the combination of optical specificity and acoustic penetration for in vivo visualization. However, its performance is limited by a trade-off between ultrasound detection aperture and sensitivity, compromising image contrast, resolution, and penetration depth. Here, we introduce three-dimensional aperture-driven photoacoustic tomography (3D-ADPAT) to overcome these limitations, synergistically combining a high–numerical-aperture focused ultrasonic transducer (HNA-FUT) with a phase-inverted focusing-equivalent reconstruction (PIFER) algorithm. This approach yields ~2.21-fold enhancement in spatial resolution and ~10-fold increase in contrast-to-noise ratio. 3D-ADPAT’s performance was validated through comprehensive simulations and phantom studies and further confirmed by in vivo whole-body imaging that resolved deep-seated anatomies and tracked small-molecule metabolic pathways. Furthermore, a barrel-shaped array–based 3D-ADPAT implementation was designed, supporting dynamic imaging within a large field of view or across variable spatiotemporal scales. In summary, 3D-ADPAT provides a powerful tool for advanced photoacoustic systems, promising to accelerate frontier biomedical research.


  • Photoacoustic Tomography Tracks Vascular Remodeling and Functional Recovery in Liver Regeneration

    by Fan Meng, Xiali Gao, Hao Huang, Zhibo Xiao, Xuran Zhou, Yiyin Su, Ruimin Chen, Yang Xiao, Dikui Zhou, Yuqi Wang, et al.

    Objective: This study aims to longitudinally monitor hepatic vascular remodeling and functional recovery during liver regeneration in mice using 3-dimensional panoramic photoacoustic computed tomography (3D-PanoPACT). Impact Statement: By enabling noninvasive, whole-organ spatiotemporal tracking within the same animal, this work establishes a novel imaging framework for staging organ regeneration and mapping vascular dynamics. Introduction: Hepatic vascular remodeling is critical for successful liver regeneration; however, existing imaging modalities lack the capacity for noninvasive, longitudinal, 3D characterization at the whole-organ scale. Methods: Male nude mice under isoflurane anesthesia underwent 70% partial hepatectomy or served as controls. A custom 3D-PanoPACT system performed continuous whole-organ imaging over 16 d. Quantitative vascular parameters, contrast clearance kinetics, and histological validation via hematoxylin and eosin and CD31 staining were assessed. Serum biochemical analyses independently evaluated hepatobiliary functional recovery. Results: 3D-PanoPACT delineated 3 temporally distinct vascular remodeling phases: proliferative (days 2 to 4), recovery (days 5 to 9), and remodeling (days 10 to 16). By day 16, regenerated livers exhibited no significant differences from normal controls in vascular volume, vessel length, mean diameter, or branching density, which was further confirmed by CD31 evaluation. While functional imaging showed a slightly delayed early peak enhancement, long-term metabolic clearance remained similar to that of normal controls. This functional recovery was independently corroborated by normal-like serum biochemical profiles at day 16. Conclusion: 3D-PanoPACT enables noninvasive, longitudinal tracking of hepatic regeneration. By delineating distinct morphological phases and complementing them with metabolic and biochemical validations, this framework effectively maps macroscopic vascular remodeling and confirms adequate functional recovery by day 16.